Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies.

Authors:
Julita Machlowska Jacek Baj Monika Sitarz Ryszard Maciejewski Robert Sitarz

Int J Mol Sci 2020 Jun 4;21(11). Epub 2020 Jun 4.

Department of Human Anatomy, Medical University of Lublin, 20-090 Lublin, Poland.

Gastric cancer (GC) is one of the most common malignancies worldwide and it is the fourth leading cause of cancer-related death. GC is a multifactorial disease, where both environmental and genetic factors can have an impact on its occurrence and development. The incidence rate of GC rises progressively with age; the median age at diagnosis is 70 years. However, approximately 10% of gastric carcinomas are detected at the age of 45 or younger. Early-onset gastric cancer is a good model to study genetic alterations related to the carcinogenesis process, as young patients are less exposed to environmental carcinogens. Carcinogenesis is a multistage disease process specified by the progressive development of mutations and epigenetic alterations in the expression of various genes, which are responsible for the occurrence of the disease.

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms21114012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312039PMC
June 2020

Publication Analysis

Top Keywords

gastric cancer
12
detected age
4
carcinomas detected
4
10% gastric
4
age younger
4
gastric carcinomas
4
early-onset gastric
4
model study
4
good model
4
cancer good
4
years 10%
4
younger early-onset
4
diagnosis years
4
rate rises
4
incidence rate
4
development incidence
4
occurrence development
4
rises progressively
4
progressively age
4
age diagnosis
4

Keyword Occurance

Similar Publications

Red and processed meat consumption and cancer outcomes: Umbrella review.

Authors:
Yin Huang Dehong Cao Zeyu Chen Bo Chen Jin Li Jianbing Guo Qiang Dong Liangren Liu Qiang Wei

Food Chem 2021 Mar 27;356:129697. Epub 2021 Mar 27.

Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address:

The purpose of this umbrella review was to evaluate the quality of evidence, validity and biases of the associations between red and processed meat consumption and multiple cancer outcomes according to existing systematic reviews and meta-analyses. The umbrella review identified 72 meta-analyses with 20 unique outcomes for red meat and 19 unique outcomes for processed meat. Red meat consumption was associated with increased risk of overall cancer mortality, non-Hodgkin lymphoma (NHL), bladder, breast, colorectal, endometrial, esophageal, gastric, lung and nasopharyngeal cancer. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Projections of the future burden of cancer in Australia using Bayesian age-period-cohort models.

Authors:
Jessica Katherine Cameron Peter Baade

Cancer Epidemiol 2021 Apr 7;72:101935. Epub 2021 Apr 7.

The Viertel Cancer Research Centre, Cancer Council Queensland, PO Box 201, Spring Hill, Brisbane, Queensland, 4004, Australia; School of Mathematical Sciences, Queensland University of Technology, GPO Box 2434, Brisbane, Queensland, 4001, Australia; Menzies Health Institute Queensland, Griffith University, G40 Griffith Health Centre, Gold Coast Campus, Queensland, Gold Coast, 4222, Australia. Electronic address:

Background: Accurate forecasts of cancer incidence, with appropriate estimates of uncertainty, are crucial for planners and policy makers to ensure resource availability and prioritize interventions. We used Bayesian age-period-cohort (APC) models to project the future incidence of cancer in Australia.

Methods: Bayesian APC models were fitted to counts of cancer diagnoses in Australia from 1982 to 2016 and projected to 2031 for seven key cancer types: breast, colorectal, liver, lung, non-Hodgkin lymphoma, melanoma and stomach. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Gender Differences in Treatment Allocation and Survival of Advanced Gastroesophageal Cancer: a Population-Based Study.

Authors:
Willemieke P M Dijksterhuis Marianne C Kalff Anna D Wagner Rob H A Verhoeven Valery E P P Lemmens Martijn G H van Oijen Suzanne S Gisbertz Mark I van Berge Henegouwen Hanneke W M van Laarhoven

J Natl Cancer Inst 2021 Apr 10. Epub 2021 Apr 10.

Amsterdam UMC, University of Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands.

Background: Biological sex and gender have been reported to impact incidence and overall survival (OS) of curatively treated gastroesophageal cancer. The aim of this study was to compare palliative treatment allocation and OS between women and men with advanced gastroesophageal cancer.

Methods: Patients with an unresectable (cT4b) or metastatic (cM1) esophageal (including cardia) adenocarcinoma (EAC) or squamous cell carcinoma (ESCC), or gastric adenocarcinoma (GAC) diagnosed in 2015-2018 were identified in the Netherlands Cancer Registry. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer.

Authors:
Anqi Cheng Xiong Guo Xinglong Dai Ziwei Wang

FEBS Open Bio 2021 Apr 10. Epub 2021 Apr 10.

Department of Gastrointestinal Surgery, Laboratory Research Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, PR China.

The transcriptional repressor Zinc-finger and homeoboxes 2 (ZHX2) is reported to regulate tumor progression in several human cancers, but little is known about its role in gastric cancer (GC). In this study, we examined the expression of ZHX2 and its relationship with clinicopathological characteristics and prognosis of GC patients, and examined the effect of ZHX2 overexpression in GC cell lines. We used UALCAN and Tumor Immune Estimation Resource (TIMER) to examine ZHX2 mRNA expression, and used Kaplan-Meier plotter to determine whether ZHX2 expression was related to GC prognosis. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Drug-exposed cancer-associated fibroblasts facilitate gastric cancer cell progression following chemotherapy.

Authors:
Takahiro Ishii Ayako Suzuki Takeshi Kuwata Shoshi Hisamitsu Hiroko Hashimoto Yuuki Ohara Kazuyoshi Yanagihara Shuichi Mitsunaga Takayuki Yoshino Takahiro Kinoshita Atsushi Ochiai Kohei Shitara Genichiro Ishii

Gastric Cancer 2021 Apr 9. Epub 2021 Apr 9.

Division of Pathology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.

Background: Cancer progression following chemotherapy is a significant barrier to effective cancer treatment. We aimed to evaluate the role of drug-exposed cancer-associated fibroblasts (CAFs) in the growth and progression of drug-exposed gastric cancer (GC) cells and to explore the underlying molecular mechanism.

Methods: The human GC cell line 44As3 and CAFs were treated with 5-fluorouracil and oxaliplatin (5FU + OX). Read More

View Article and Full-Text PDF
April 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap